Featured Stocks on Today's Edition of The Analyst's Review: TWX, TWC, CBS, VIA, HTV, SIRI

A recent interview with Dr. Steffen Nock, Head of U.S. Operations for Arana Therapeutics Ltd. (ASX: AAH) is also available now at WallSt.net (www.wallst.net) 


NEW YORK, Jan. 4  /PRNewswire/ -- The Analyst's Review is a daily podcast hosted by WallSt.net editor, Henry Truc that airs every morning at 9 a.m. EST on http://radio.wallst.net/profile.asp?id=193.

The show features informative interviews with Wall Street analysts on a wide range of topics including actively traded stocks, market movers, various industries, and macro economic trends affecting the market.

On today's show, Jim Goss, analyst for Barrington Research discussed Time Warner, Inc. (NYSE: TWX; http://www.timewarner.com/), Time Warner Cable, Inc. (NYSE: TWC; http://www.timewarnercable.com/), CBS Corp. (NYSE: CBS; http://www.cbscorporation.com/), Viacom, Inc. (NYSE: VIA; http://www.viacom.com/), Hearst- Argyle Television, Inc. (NYSE: HTV; http://www.hearstargyle.com/), Sirius Satellite Radio, Inc. (Nasdaq: SIRI; http://www.siriusradio.com/).

"CBS had a strong run earlier in the year and got into the mid-$30s," Goss said. "It's backed off to a little under $26. I think at least part of that is probably due to some of the implications of the writer's strike, but partly as a reaction to how far it moved so quickly."

Hear what else Goss had to say about today's featured stocks by visiting http://radio.wallst.net/. Click on "The Analyst's Review - Stocks in Focus: TWX, TWC, CBS, VIA, HTV, SIRI" to hear the podcast in its entirety.

A November 2 interview with Dr. Steffen Nock, Head of U.S. Operations for Arana Therapeutics Ltd. (ASX:AAH) is also available now at http://www.wallst.net/.

Arana Therapeutics Limited, created through the merger of Peptech Limited and EvoGenix Limited in August 2007, is a biotechnology company dedicated to developing and providing antibody and peptide-based human therapeutic products for the treatment of cancer and inflammatory diseases.

  Interview highlights include detailed discussions on the following topics:

  --  reasons for the merger between Peptech Ltd. and EvoGenix Ltd.
  --  applications for the company's technology
  --  the company's "fairly deep pipeline"
  --  "uncommon" characteristics of the company
  --  Upcoming development milestones for investors to watch for




To hear the interview in its entirety, and to read an in-depth report on the company, visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=ASX:AAH

Read what others have to say about Arana Therapeutics, or post your own comments about the company on its message board at: http://www.mywallst.net/forum/viewtopic.php?t=277

About WallStRadio.com

WallStRadio.com is owned and operated by WallStreet Direct, Inc., a wholly-owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com/). The Web site offers free access to original content, and more than 150 business and finance podcasts from well- known business news personalities and organizations. WallStreet Direct, Inc. also owns and operates WallSt.net (http://www.wallst.net/), a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net/, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com/), a provider of media and compliance solutions to publicly traded companies. The investment professional featured in this podcast and/or their firm may own securities in the companies mentioned in this podcast. We have received seven thousand five hundred dollars from Arana Therapeutics for media and advertising services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp

   Contact:
   Henry Truc
   WallStRadio.com
   1-800-4-WallSt


DATASOURCE: WallStreet Direct, Inc.



CONTACT:  Henry Truc of WallStRadio.com, 1-800-4-WallSt



Web site:  http://www.wallst.net/ 

Copyright